Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 02, 2015 08:00 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals to Present at Wells Fargo 2015 Healthcare Conference

BOTHELL, Wash., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ("Alder") (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the...
August 20, 2015 08:00 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Appoints Paul B. Cleveland to Board of Directors

BOTHELL, Wash., Aug. 20, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ("Alder") (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the...
August 05, 2015 16:02 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Reports Second Quarter 2015 Financial and Operating Results

BOTHELL, Wash., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ("Alder") (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the...
July 29, 2015 08:00 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals to Host Conference Call to Discuss Second Quarter 2015 Financial and Operating Results

BOTHELL, Wash., July 29, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ("Alder") (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the...
June 30, 2015 16:01 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares

BOTHELL, Wash., June 30, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company, announced today that the underwriters of its previously...
June 26, 2015 16:02 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals to Present at WBBA 2015 Life Science Innovation Northwest Conference

BOTHELL, Wash., June 26, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company, today announced that Randall C. Schatzman, Ph.D., President...
June 25, 2015 19:52 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Prices Public Offering of Common Stock

BOTHELL, Wash., June 25, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq:ALDR), a clinical-stage biopharmaceutical company, announced today the pricing of an underwritten public...
June 24, 2015 16:01 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals Announces Commencement of Public Offering of Common Stock

BOTHELL, Wash., June 24, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq:ALDR), a clinical-stage biopharmaceutical company, announced today that it intends to offer and sell, subject...
May 28, 2015 08:00 ET | Source: Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference

BOTHELL, Wash., May 28, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ("Alder") (Nasdaq:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the...
May 15, 2015 08:00 ET | Source: Alder BioPharmaceuticals, Inc.

Alder Presents Positive Clinical Data for ALD403 at the 17th Congress of the International Headache Society

BOTHELL, Wash., May 15, 2015 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ("Alder") (Nasdaq:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the...